Aron Popovtzer

7.7k total citations · 1 hit paper
134 papers, 2.9k citations indexed

About

Aron Popovtzer is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aron Popovtzer has authored 134 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 44 papers in Otorhinolaryngology and 42 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aron Popovtzer's work include Head and Neck Cancer Studies (38 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Ear and Head Tumors (15 papers). Aron Popovtzer is often cited by papers focused on Head and Neck Cancer Studies (38 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Ear and Head Tumors (15 papers). Aron Popovtzer collaborates with scholars based in Israel, United States and Italy. Aron Popovtzer's co-authors include Rachela Popovtzer, Avraham Eisbruch, Thomas E. Carey, Ashish Agrawal, James M. Balter, Raoul Kopelman, Nicholas A. Kotov, Menachem Motiei, Oshra Betzer and Yue Cao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Aron Popovtzer

115 papers receiving 2.8k citations

Hit Papers

Targeted Gold Nanoparticles Enable Molecular CT Imaging o... 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aron Popovtzer Israel 28 823 658 573 571 520 134 2.9k
Jason M. Warram United States 32 1.8k 2.1× 228 0.3× 413 0.7× 767 1.3× 549 1.1× 91 3.2k
Pei‐Jen Lou Taiwan 38 809 1.0× 1.0k 1.6× 1.2k 2.1× 1.2k 2.0× 1.1k 2.2× 183 4.6k
Si Yeol Song South Korea 27 433 0.5× 221 0.3× 511 0.9× 1.1k 1.9× 774 1.5× 157 2.6k
Sunil Gulavita Canada 14 230 0.3× 398 0.6× 465 0.8× 1.0k 1.8× 771 1.5× 20 2.8k
Eun Kyung Choi South Korea 41 927 1.1× 342 0.5× 1.1k 2.0× 1.8k 3.2× 1.9k 3.7× 259 6.2k
Jean‐Philippe Pignol Canada 39 809 1.0× 185 0.3× 800 1.4× 2.1k 3.6× 1.3k 2.5× 163 6.4k
Michael T. Spiotto United States 27 645 0.8× 439 0.7× 423 0.7× 926 1.6× 1.6k 3.0× 99 3.8k
Stijn Keereweer Netherlands 23 753 0.9× 298 0.5× 492 0.9× 499 0.9× 319 0.6× 67 1.7k
Leslie Tupchong United States 15 545 0.7× 460 0.7× 342 0.6× 288 0.5× 302 0.6× 28 1.7k
J.S.W. Stewart United Kingdom 20 535 0.7× 248 0.4× 196 0.3× 435 0.8× 581 1.1× 36 2.1k

Countries citing papers authored by Aron Popovtzer

Since Specialization
Citations

This map shows the geographic impact of Aron Popovtzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aron Popovtzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aron Popovtzer more than expected).

Fields of papers citing papers by Aron Popovtzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aron Popovtzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aron Popovtzer. The network helps show where Aron Popovtzer may publish in the future.

Co-authorship network of co-authors of Aron Popovtzer

This figure shows the co-authorship network connecting the top 25 collaborators of Aron Popovtzer. A scholar is included among the top collaborators of Aron Popovtzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aron Popovtzer. Aron Popovtzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrington, Kevin J., Stéphane Champiat, Joshua Brody, et al.. (2025). Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas. Clinical Cancer Research. 31(16). 3400–3411. 10 indexed citations
4.
Kumar, Awanish, Ariel M. Rubinstein, Jawad Abu-Tair, et al.. (2025). Effective head and neck cancer treatment combines radiation and local extended cisplatin release. Journal of Controlled Release. 384. 113923–113923.
5.
Dinstag, Gal, Yaron Kinar, Yakir Rottenberg, et al.. (2025). Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics. Journal for ImmunoTherapy of Cancer. 13(1). e010132–e010132. 1 indexed citations
6.
Vainer, Igor, et al.. (2024). Post‐radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factors. Clinical Otolaryngology. 49(4). 506–511.
9.
Levin, E G, Amit Ritter, Gideon Bachar, et al.. (2024). Management of laryngeal chondroradionecrosis: A single‐center experience. Head & Neck. 47(1). 300–308. 1 indexed citations
11.
Popovtzer, Aron, et al.. (2023). Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine. 12(4). 1277–1277. 7 indexed citations
12.
Greil, Richard, Barbara Burtness, Simon Laban, et al.. (2023). 106P Treatment sequencing in PD-L1–positive recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Exploratory analysis of the phase III KEYNOTE-048 study. Immuno-Oncology Technology. 20. 100578–100578. 1 indexed citations
13.
Feliciani, Giacomo, Manuela Monti, Ignazio Stanganelli, et al.. (2022). A New Approach for a Safe and Reproducible Seeds Positioning for Diffusing Alpha-Emitters Radiation Therapy of Squamous Cell Skin Cancer: A Feasibility Study. Cancers. 14(1). 240–240. 5 indexed citations
14.
Mizrachi, Aviram, et al.. (2020). Cetuximab Bound Gold Nanoparticles Added to Standard Chemotherapy and Radiation Therapy: An In Vivo Glioblastoma Mouse Model. International Journal of Radiation Oncology*Biology*Physics. 108(3). e505–e505. 2 indexed citations
15.
Popovtzer, Aron, Muhammed Iraqi, Angel Porgador, et al.. (2020). CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine. 9(10). 3214–3214. 6 indexed citations
16.
Popovtzer, Aron, Eli Rosenfeld, Aviram Mizrachi, et al.. (2019). Initial Safety and Tumor Control Results From a “First-in-Human” Multicenter Prospective Trial Evaluating a Novel Alpha-Emitting Radionuclide for the Treatment of Locally Advanced Recurrent Squamous Cell Carcinomas of the Skin and Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 106(3). 571–578. 44 indexed citations
17.
Vidal, Liat, et al.. (2017). Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer—Systematic Review and Meta-analysis. The Cancer Journal. 23(2). 79–83. 20 indexed citations
18.
Popovtzer, Aron, et al.. (2014). MRI to delineate the gross tumor volume of nasopharyngeal cancers: which sequences and planes should be used?. Radiology and Oncology. 48(3). 323–330. 9 indexed citations
19.
Rancati, T., Marco Schwarz, Aaron M. Allen, et al.. (2010). Radiation Dose–Volume Effects in the Larynx and Pharynx. International Journal of Radiation Oncology*Biology*Physics. 76(3). S64–S69. 165 indexed citations
20.
Marshak, Gideon & Aron Popovtzer. (2006). Is there any significant reduction of patients' outcome following delay in commencing postoperative radiotherapy?. Archive ouverte UNIGE (University of Geneva). 14(2). 82–84. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026